Cargando…
Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing
BACKGROUND: Levetiracetam is an anticonvulsant used for control of canine epilepsy. An extended release preparation should improve dosing convenience. OBJECTIVES: To determine the disposition of extended release levetiracetam in normal dogs after single dosing. ANIMALS: Pharmacokinetic study: 16 hea...
Autores principales: | Beasley, M.J., Boothe, D.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858031/ https://www.ncbi.nlm.nih.gov/pubmed/26290357 http://dx.doi.org/10.1111/jvim.13588 |
Ejemplares similares
-
Pharmacokinetics of Single Oral Dose Extended‐Release Levetiracetam in Healthy Cats
por: Barnard, L., et al.
Publicado: (2017) -
Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats
por: Barnes Heller, Heidi, et al.
Publicado: (2018) -
Population pharmacokinetics of extended‐release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide
por: Muñana, Karen R., et al.
Publicado: (2018) -
Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats
por: Smith, Casey, et al.
Publicado: (2019) -
Effects of oral administration of 5 immunosuppressive agents on activated T‐cell cytokine expression in healthy dogs
por: Archer, Todd M., et al.
Publicado: (2020)